Gossamer Bio Stock Quote GOSS - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.0011

Bid

1.00

Ask

1.01

Volume

13,115,744

0.762 Day's Range 1.10

0.4993 52 Week Range 1.60

Market Cap

226.853M

Previous Close

0.7126

Open

0.83

Last Trade

1.005

Last Trade Time

12:13:00

Financial Volume

$ 12,319,990

VWAP

0.939328

Average Volume (3m)

1,021,519

Shares Outstanding

226,604,137

Dividend Yield

PE Ratio

-1.18

Earnings Per Share (EPS)

-0.79

Revenue

Net Profit

-179.82M

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth,... Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.gossamerbio.com

Headquarters

Wilmington, Delaware, USA

Founded

Gossamer Bio Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GOSS. The last closing price for Gossamer Bio was $0.71. Over the last year, Gossamer Bio shares have traded in a share price range of $ 0.4993 to $ 1.60.

Gossamer Bio currently has 226,604,137 shares outstanding. The market capitalization of Gossamer Bio is $161.48 million. Gossamer Bio has a price to earnings ratio (PE ratio) of -1.18.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.2983	42.4445076836	0.7028	1.1	0.6666	1988022	0.72412293	CS
4	0.1811	22.0853658537	0.82	1.1	0.6617	1386332	0.71743608	CS
12	0.0611	6.5	0.94	1.11	0.6617	1021519	0.84919304	CS
26	0.4736	89.7819905213	0.5275	1.37	0.5104	1485924	0.86656047	CS
52	-0.0489	-4.65714285714	1.05	1.6	0.4993	1444482	0.91181132	CS
156	-9.1989	-90.1852941176	10.2	15.195	0.4525	2007060	3.00903584	CS
260	-25.5789	-96.2336343115	26.58	27.1497	0.4525	1442633	4.4351449	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
GOEVCanoo Inc	$ 0.2639 (103.00%)	679.1M
PALIPalisade Bio Inc	$ 2.38 (70.00%)	53.93M
TRVITrevi Therapeutics Inc	$ 4.00 (60.64%)	45.02M
LAESSEALSQ Corporation	$ 1.64 (42.61%)	179.89M
GOSSGossamer Bio Inc	$ 0.9994 (40.25%)	12.85M
SPGCSacks Parente Golf Inc	$ 0.3495 (-75.04%)	17.7M
KROSKeros Therapeutics Inc	$ 17.925 (-73.89%)	9.94M
SFHGSamfine Creation Holdings Group Ltd	$ 1.35 (-55.74%)	5.23M
TFFPTFF Pharmaceuticals Inc	$ 0.0748 (-54.03%)	3.36M
BCTXBriaCell Therapeutics Corporation	$ 0.6301 (-42.72%)	5.46M
GOEVCanoo Inc	$ 0.26395 (103.04%)	679.24M
LAESSEALSQ Corporation	$ 1.635 (42.17%)	179.9M
CDTConduit Pharmaceuticals Inc	$ 0.0826 (-6.46%)	98.47M
RGTIRigetti Computing Inc	$ 7.0986 (-3.81%)	94.78M
NVDANVIDIA Corporation	$ 136.7799 (-1.82%)	74.87M